https://adisinsight.springer.com/trials/700006637?error=cookies_not_supported&code=f6b8af5f-e156-40d1-abde-7635aa75805a
A phase II study of OSI-774 (Tarceva) [erlotinib] in combination with capecitabine in previously...
This phase II trial is designed to investigate the effectiveness of Tarceva (OSI-774) combined with capecitabine in treating patients with metastatic
https://adisinsight.springer.com/trials/700038657?error=cookies_not_supported&code=8a377667-dff8-46d5-82e8-db5e7459b6c9
A Phase 2 Randomized Open-Label Study of Neratinib Versus Lapatinib Plus Capecitabine for the...
This non-inferiority trial is comparing the efficacy and tolerability of neratinib [HKI-272; Wyeth] with lapatinib [Tykerb, Tyverb] + capecitabine [Xeloda] in
https://adisinsight.springer.com/drugsafety/803911351?error=cookies_not_supported&code=2ef6cd91-cabf-4850-89a2-cc3e8461a1d5
Capecitabine/Oxaliplatin - AdisInsight
A cohort of 32 patients (median age 42 years, 66% male) with locally advanced rectal cancer received total neoadjuvant therapy consisting of short-course
capecitabineoxaliplatinadisinsight
https://adisinsight.springer.com/trials/700271151?error=cookies_not_supported&code=af478869-05ca-40de-9eaf-f1fbfa636201
Phase I study of a combination of capecitabine plus CPT-11 (CC therapy) in patients with metastatic...
To assess the feasibility of the combination of capecitabine plus irinotecan (CC therapy) in patients with metastatic colon cancer refractory to oxaliplatin
https://researchportalplus.anu.edu.au/en/publications/multicenter-randomized-phase-ii-clinical-trial-comparing-neoadjuv/
Multicenter randomized phase II clinical trial comparing neoadjuvant oxaliplatin, capecitabine, and...
phase iiclinical trialmulticenterrandomized
https://research.birmingham.ac.uk/en/projects/effect-of-renal-impairment-on-the-pharmacokinetics-of-capecitabin/
Effect of Renal Impairment on the Pharmacokinetics of Capecitabine in Cancer Patients - University...
renal impairmenton the
https://pubmed.ncbi.nlm.nih.gov/25416687/
Docetaxel plus oxaliplatin with or without fluorouracil or capecitabine in metastatic or locally...
These results suggest that TEF is worthy of evaluation as an arm in a phase III trial or as a backbone regimen for new targeted agents in advanced GC....
docetaxelplusoxaliplatin
https://adisinsight.springer.com/trials/700134078?error=cookies_not_supported&code=62518004-390b-4e38-a0e1-02d84c69702d
Phase II trial of oral vinorelbine in combination with capecitabine as first line therapy in women...
This trial is entitled "Phase II trial of oral vinorelbine in combination with capecitabine as first line therapy in women with previously untreated HER2
https://www.fda.gov/advisory-committees/pediatric-advisory-committee/xeloda-capecitabine-briefing-materials
Xeloda (capecitabine) Briefing Materials | FDA
Briefing materials for the April 12, 2016 meeting of the FDA's Pediatric Advisory Committee
briefing materialsxelodacapecitabinefda
https://www.cochrane.org/evidence/CD011220_benefits-capecitabine-hormone-receptor-positive-compared-hormone-receptor-negative-breast-cancer
Benefits of capecitabine in hormone receptor-positive compared to hormone receptor-negative breast...
hormone receptor positivebenefits ofcapecitabine
https://pubmed.ncbi.nlm.nih.gov/27859657/
Capecitabine and adermatoglyphia: trouble in border!
Capecitabine and adermatoglyphia: trouble in border!
capecitabinetroubleborder
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCT02614794&r=1
A Study of Tucatinib vs. Placebo in Combination With Capecitabine & Trastuzumab in Patients With...
a study
https://experts.arizona.edu/en/publications/capecitabine-therapy-for-refractory-metastatic-thyroid-carcinoma-/
Capecitabine therapy for refractory metastatic thyroid carcinoma: A case series - University of...
thyroid carcinoma
https://pubmed.ncbi.nlm.nih.gov/28182248/
Coadministration of proton pump inhibitors and the efficacy of capecitabine in patients with...
Coadministration of proton pump inhibitors and the efficacy of capecitabine in patients with advanced adenocarcinoma of the small bowel or ampulla of vater
proton pump inhibitorsand the
https://adisinsight.springer.com/drugsafety/803239192?error=cookies_not_supported&code=1f7b1635-fa29-4b4a-ae80-94fcc443a71f
Capecitabine - AdisInsight
In a study, 2 patients [ages and sexes not stated] were described, out of which 1 patient developed proctitis and 1 patient developed urgencies, stool
capecitabineadisinsight
https://adisinsight.springer.com/drugsafety/803220972?error=cookies_not_supported&code=32f2a23c-59b3-429e-a6aa-a13bf50bfc4b
Capecitabine - AdisInsight
In a retrospective study, four patients [ages and sexes not stated] were described, who developed hand foot syndrome, diarrhoea, mucositis, haematologic
capecitabineadisinsight
https://adisinsight.springer.com/drugsafety/803347370?error=cookies_not_supported&code=88f68479-6fc4-4364-b7cc-58ee4877a1d6
Capecitabine/cobimetinib/vemurafenib - AdisInsight
In a case report, two women were described, out of whom one developed acute coronary syndrome due to coronary vasospasm during treatment with capecitabine for
capecitabinecobimetinibvemurafenibadisinsight
https://experts.mcmaster.ca/scholarly-works/2552570
191 Phase II trial of gemcitabine and capecitabine...
Learn about the scholarly work entitled 191 Phase II trial of gemcitabine and capecitabine...
phase iitrialgemcitabinecapecitabine
https://adisinsight.springer.com/drugsafety/803396543?error=cookies_not_supported&code=5c881ef6-b5f0-46cc-a028-f0020cf09ff5
Capecitabine/cisplatin/trastuzumab - AdisInsight
An 82-year-old man developed neutropenia, cardiotoxicity and exacerbation of hand-foot syndrome during treatment with cisplatin, trastuzumab or capecitabine for
capecitabinecisplatintrastuzumabadisinsight
https://openresearch.surrey.ac.uk/esploro/outputs/journalArticle/Implementation-of-capecitabine-Xeloda-into-a/99514745902346
Implementation of capecitabine (Xeloda) into a cancer centre: UK experience. - University of Surrey
Switching patients from intravenous 5-FU/LV to oral capecitabine (Xeloda) for the treatment of metastatic colorectal cancer is associated with a reduction in...
https://seer.cancer.gov/oncologytoolbox/canmed/ndconc/65162-0843/
65162-0843 Capecitabine - CanMED: NDC
CanMED: NDC. The Cancer Medications Enquiry Database (CanMED) is a two-part resource for cancer drug treatment related studies.
capecitabinendc
https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-looking-at-capecitabine-with-or-without-bevacizumab-for-colorectal-cancer
A trial looking at capecitabine with or without bevacizumab for colorectal cancer (QUASAR 2)
This trial compared capecitabine and bevacizumab with capecitabine alone for bowel (colorectal) cancer.
https://www.cancer.gov/research/participate/clinical-trials/intervention/capecitabine
Clinical Trials Using Capecitabine - NCI
NCI supports clinical trials that test new and more effective ways to treat cancer. Find clinical trials studying capecitabine.
clinical trialsusingcapecitabinenci
https://seer.cancer.gov/oncologytoolbox/canmed/ndconc/69097-0948/
69097-0948 Capecitabine - CanMED: NDC
CanMED: NDC. The Cancer Medications Enquiry Database (CanMED) is a two-part resource for cancer drug treatment related studies.
capecitabinendc
https://researchportal.helsinki.fi/fi/publications/adjuvant-capecitabine-for-early-breast-cancer-15-year-overall-sur/
Adjuvant Capecitabine for Early Breast Cancer: 15-Year Overall Survival Results From a Randomized...
https://portal.fis.tum.de/en/publications/capecitabine-for-treatment-of-advanced-hepatocellular-carcinoma-2/
Capecitabine for treatment of advanced hepatocellular carcinoma - Technical University of Munich
hepatocellular carcinomatechnical universitycapecitabinetreatmentadvanced
https://adisinsight.springer.com/drugsafety/803722067?error=cookies_not_supported&code=3b404bee-28c6-4b6e-8b74-9873a77db0d6
Capecitabine/oxaliplatin - AdisInsight
A 64-year-old man developed myelosuppression during treatment with capecitabine and oxaliplatin for triple malignancy of the stomach, rectum and liver [routes,
capecitabineoxaliplatinadisinsight
https://pubmed.ncbi.nlm.nih.gov/37676712/
Efficacy of Capecitabine and Temozolomide Regimen in Neuroendocrine Tumors: Data From the Turkish...
The substantial superior outcomes in patients receiving first-line CAPTEM treatment highlight its potential as an effective treatment strategy for patients...
https://adisinsight.springer.com/drugsafety/803914642?error=cookies_not_supported&code=fe2002f2-fad7-49e8-b369-8a094c07dfa3
Capecitabine/Gimeracil/oteracil/tegafur/Oxaliplatin - AdisInsight
A retrospective study included 22 patients with stage IV gastric cancer and gastric outlet obstruction who underwent modified laparoscopic stomach-partitioning
capecitabineoxaliplatinadisinsight
https://ce.massmed.nejm.org/nejm-weekly-cme/content/tucatinib-trastuzumab-and-capecitabine-her2-positive-metastatic-breast-cancer
Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer | MMS/NEJM...
metastatic breast cancer
https://pubmed.ncbi.nlm.nih.gov/25302025/
Capecitabine-induced cardiotoxicity: more evidence or clinical approaches to protect the patients'...
Fluoropyrimidines, such as capecitabine and 5-fluorouracil, may cause cardiac toxicity. In recent years, the incidence of this side effect has increased and it...
more evidence
https://pubmed.ncbi.nlm.nih.gov/31881136/
Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer
Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer
metastatic breasttucatinibtrastuzumabcapecitabinepositive
https://adisinsight.springer.com/drugsafety/803850230?error=cookies_not_supported&code=62cee504-7e72-422d-940b-ee7172efe5fe
Capecitabine, risk of metabolic acidosis - AdisInsight
A safety signal of capecitabine and the risk of metabolic acidosis has been detected as a result of pharmacovigilance monitoring by the Saudi Food and Drug
metabolic acidosiscapecitabineriskadisinsight
https://adisinsight.springer.com/drugsafety/801127635?error=cookies_not_supported&code=e8b4dcf1-f990-4601-990a-b09ed581afaa
Capecitabine - AdisInsight
A 68-year-old woman developed colitis cystica superficialis during treatment with capecitabine for metastatic bilateral breast cancer.The woman presented with a
capecitabineadisinsight
https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2023.1138357/full
Frontiers | Effectiveness and safety of capecitabine, irinotecan and panitumumab in advanced...
Introduction: Capecitabine, irinotecan, and panitumumab (CAPIRI-P) is a controversial regimen for metastatic colorectal cancer, with concerns regarding the e...
frontierseffectivenesssafetycapecitabineirinotecan
https://portal.fis.tum.de/en/publications/lapatinib-versus-lapatinib-plus-capecitabine-as-second-line-treat/
Lapatinib versus lapatinib plus capecitabine as second-line treatment in human epidermal growth...
second line
https://pubmed.ncbi.nlm.nih.gov/21052661/
Phase II study of radiopeptide 177Lu-octreotate and capecitabine therapy of progressive...
The addition of capecitabine radiosensitizing chemotherapy does not increase the minimal toxicity of (177)Lu-octreotate radiopeptide therapy and led to an ORR...
phase iistudy
https://connect.mayoclinic.org/discussion/capecitabine-xoleda-and-weight-gain/?commentsorder=newest
Capecitabine (Xeloda) and Weight Gain | Mayo Clinic Connect
I started Capecitabine on June 9, 2022. Since starting this medicine, I have gained almost 20 pounds (within 2 months). Latest weight taken today at...
weight gainmayo cliniccapecitabinexelodaconnect
https://pubmed.ncbi.nlm.nih.gov/28211921/
Metronomic capecitabine versus best supportive care as second-line treatment in hepatocellular...
Preliminary studies suggest that capecitabine may be safe and effective in HCC patients. The aim of this study was to retrospectively evaluate the safety and...
supportive care
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0b59e98c-5b34-4b93-90f6-20526f4d4f88&audience=professional
DailyMed - CAPECITABINE- capecitabine tablet, film coated
dailymedcapecitabinetabletfilmcoated
https://adisinsight.springer.com/drugsafety/803928059?error=cookies_not_supported&code=23db559b-551f-4d2c-94af-6454daf7d578
Capecitabine/Peposertib - AdisInsight
Three patients [age and sex not stated] with rectal cancer in a phase Ib study received neoadjuvant capecitabine-based chemoradiation combined with peposertib
capecitabineadisinsight
https://pmc.ncbi.nlm.nih.gov/articles/PMC4256612/
Incidence and relative risk of grade 3 and 4 diarrhoea in patients treated with capecitabine or 5-...
Capecitabine is an oral fluoropyrimidine that can effectively replace infusional 5-fluorouracil (5-FU) for treatment of colorectal, gastric and breast cancer....
https://adisinsight.springer.com/trials/700392189?error=cookies_not_supported&code=b48441c3-957c-4114-85eb-9d9be9ee2178
Short-Course Radiotherapy Followed by Liposomal Irinotecan, Capecitabine, and Camrelizumab as...
This study is for adults with locally advanced rectal cancer that has not spread to distant organs, and is classified as pMMR or MSS (which means it typically
short coursefollowed byradiotherapy
https://seer.cancer.gov/oncologytoolbox/canmed/ndconc/68001-0643/
68001-0643 Capecitabine - CanMED: NDC
CanMED: NDC. The Cancer Medications Enquiry Database (CanMED) is a two-part resource for cancer drug treatment related studies.
capecitabinendc
https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-of-bortezomib-with-epirubicin-carboplatin-and-capecitabine-chemotherapy-for-cancer-where-the-food-pipe-meets-the-stomach
A trial of bortezomib with epirubicin, carboplatin and capecitabine chemotherapy for cancer where...
This trial looked at the drug bortezomib with chemotherapy for cancer that started where the food pipe (oesophagus) meets the stomach.
https://eprints.ncl.ac.uk/206428
Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with...
https://adisinsight.springer.com/trials/700057858?error=cookies_not_supported&code=08ae7530-4bd8-4c1d-a5c5-a9a448a98429
Clinical Outcomes on ErbB2+ MBC Patients Treated With Lapatinib-Capecitabine After Trastuzumab...
This study is investigating the efficacy and tolerability of early versus late lapatinib + capecitabine, initiated immediately after progression on trastuzumab
clinical outcomes